Adolescent use of insulin and patient-controlled analgesia pump technology: A 10-year food and drug administration retrospective study of adverse events

Pediatrics

Volumn 121, Issue 5, 2008, Pages

  Cope, Judith U ^a   Morrison, Audrey E ^a   Samuels Reid, Joy ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Adolescent; Adverse events; Analgesia; Diabetes; Infusion pump; Medical devices; Postmarket surveillance

Indexed keywords

HYDROMORPHONE; INSULIN; MORPHINE; NALOXONE; NARCOTIC ANALGESIC AGENT; PETHIDINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DEMOGRAPHY; DIABETIC COMA; DIABETIC KETOACIDOSIS; DRUG FATALITY; DRUG OVERDOSE; EDUCATIONAL STATUS; FEMALE; FOOD AND DRUG ADMINISTRATION; HIGH RISK BEHAVIOR; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFUSION PUMP; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PATIENT CONTROLLED ANALGESIA; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PUBERTY; RESPIRATION DEPRESSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SPORT; SUICIDE ATTEMPT; CHILD BEHAVIOR; CHILD PSYCHOLOGY; EQUIPMENT; INSULIN INFUSION;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT PSYCHOLOGY; ADULT; ANALGESIA, PATIENT-CONTROLLED; CHILD; EQUIPMENT FAILURE; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN INFUSION SYSTEMS; MALE;

EID: 44449108280     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-1707     Document Type: Article

References (39)

1. Miller MR, Elixhauser A, Zhan C. Patient safety events during pediatric hospitalizations. Pediatrics. 2003;111(6 pt 1): 1358-1366
2. Woods D, Thomas E, Holl J, Altman S, Brennan T. Adverse events and preventable adverse events in children. Pediatrics. 2005;115(1):155-160
3. Daneman D. Type 1 diabetes. Lancet. 2006;367(9513):847-858
4. Food and Drug Administration. Device Advice: Premarket Notification 510(k). Available at: www.fda.gov/cdrh/devadvirce/314.html#intro. Accessed February 29, 2008
5. Food and Drug Administration. Device Advice Premarket Approval (PMA). Available at: www.fda.gov/cdrh/devadvice/pma. Accessed February 29, 2008
6. JCAHO's National Patient Safety Goal for infusion pump freeflow protection: ECRI's assessment Health Devices. 2004 Dec: 33(12):430-435
7. Food and Drug Administration. Medical Device Reporting. Available at: wrww.fda.gov/cdrh/mdr. Accessed February 29, 2008
8. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care. 1999;22(11):1779-1784
9. White NH, Cleary PA, Dahms W, et al. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr. 2001;139(6):804-812
10. Weinzimer SA, Sikes KA, Steffen AT, Tamborlane WV. Insulin pump treatment of childhood type 1 diabetes. Pediatr Clin North Am. 2005;52(6):1677-1688
11. Palta M, Shen G, Allen C, Klein R, D'Alessio D. Longitudinal patterns of glycemic control and diabetes care from diagnosis in a population-based cohort with type 1 diabetes. The Wisconsin Diabetes Registry. Am J Epidemiol. 1996;144(10):954-961
12. Pound N, Sturrock NDC, Jeffcoate WJ. Age related changes in glycated haemoglobin in patients with insulin-dependent diabetes mellitus. DiabetMed. 1996;13(6):510-513
13. Grey M, BolandEA. Diabetes mellitus (type 1). In: Jackson PL, ed. Primary Care of the Child With a Chronic Condition. 2nd ed. St Louis, MO: CV Mosby; 1996:350-370
14. Moreland EC, Tovar A, Zuehlke JB, Butler DA, Milaszewski K, Laffel LM. The impact of physiological, therapeutic and psychosocial variables on glycemic control in youth with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2004;17(11): 1533-1544
15. Blackett PR. Insulin pump treatment for recurrent ketoacidosis in adolescence. Diabetes Care. 1995;18(6):881-882
16. Steindel BS, Roe TR, Costin G, Carlson M, Kaufman FR. Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract. 1995;27(3):199-204
17. Davies AG, Baum JD. A decade of insulin infusion pumps. Arch Dis Child. 1988;63(3):329-332
18. Knight G. Risks with continuous subcutaneous insulin infusion can be serious. BMJ. 2001;323(7314):693-694
19. Bode BW, Tamborlane WV, Davidson PC. Insulin pump therapy in the 21st century: strategies for successful use in adults, adolescents, and children with diabetes. Postgrad Med. 2002; 111(5):69-77
20. Alemzadeh R, Palma-Sisto P, Parton EA, Holzum MK. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes. Diabetes Technol Ther. 2005;7(4): 587-596
21. Danne T, Battelino T, Kordonouri O, et al. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. Pediatr Diabetes. 2005;6(4):193-198
22. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care. 2004;27(3): 734-738
23. Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care. 2005;28(1):15-19
24. Ahern JA, Boland EA, Doane R, et al. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes. 2002;3(1):10-15
25. Burdick J, Chase HP, Slover RH, et al. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics. 2004;113(3 pt 1). Available at: www.pediatrics.org/cgi/ content/full/113/3/er221 http://www.pediatrics.org/cgi/content/full/113/3/e221
26. Kyngas H. Compliance of adolescents with diabetes. J Pediatr Nurs. 2000;15(4):260-267
27. Plotnick LP, Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care. 2003;26(4):1142-1146
28. Goldston DB, Kovacs M, Ho VY, Parrone PL, Stiffler L. Suicidal ideation and suicide attempts among youth with insulin-dependent diabetes mellitus. J Am Acad Child Adolesc Psychiatry. 1994;33(2):240-246
29. Northam EA, Matthews LK, Anderson PJ, Cameron FJ, Werther GA. Psychiatric morbidity and health outcome in type 1 diabetes: perspectives from a prospective longitudinal study. DiabetMed. 2005;22(2):152-157
30. Knight DM, James RA, Sims DN, Bourne AJ, Martin J, Byard RW. Sudden death due to intravenous infusion of hair conditioner. Am J Forensic Med Pathol. 1998;19(3):252-254
31. Weintrob N, Benzaquen H, Galatzer A. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics. 2003;112(3 pt 1):559-564
32. Saha ME, Huuppone T, Mikael K, Juuti M, Komulainen J. Continuous subcutaneous insulin infusion in the treatment of children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2002;15(7):1005-1010
33. Grass JA. Patient-controlled analgesia. Anesth Analg. 2005; 101(5 Suppl):S44-S61
34. Doyle E, Robinson D, Morton NS. Comparison of patient-controlled analgesia with and without a background infusion after lower abdominal surgery in children. Br J Anaesth. 1993; 71(5):670-673
35. McNeely JK, Trentadue NC. Comparison of patient-controlled analgesia with and without nighttime morphine infusion following lower extremity surgery in children. J Pain Symptom Manage. 1997;13(5):268-273
36. Macintyre PE, Jarvis DA. Age is the best predictor of postoperative morphine requirements. Pain. 1996;64(2):357-364
37. Shapiro BS, Cohen DE, Howe CJ. Patient-controlled analgesia for sickle-cell-related pain. J Pain Symptom Manage. 1993;8(1): 22-28
38. Marders J. PCA by proxy: too much of a good thing. Nursing. 2004;34(4):24
39. JCAHO's National Patient Safety Goal for infusion pump freeflow protection: ECRI's assessment of the protection offered by general-purpose, PCA, and ambulatory pumps. Health Devices. 2004;33(12):430-435